16-70481160-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015386.3(COG4):c.2236-16A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00593 in 1,613,006 control chromosomes in the GnomAD database, including 541 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.032 ( 297 hom., cov: 32)
Exomes 𝑓: 0.0032 ( 244 hom. )
Consequence
COG4
NM_015386.3 intron
NM_015386.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.699
Genes affected
COG4 (HGNC:18620): (component of oligomeric golgi complex 4) The protein encoded by this gene is a component of an oligomeric protein complex involved in the structure and function of the Golgi apparatus. Defects in this gene may be a cause of congenital disorder of glycosylation type IIj. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-70481160-T-C is Benign according to our data. Variant chr16-70481160-T-C is described in ClinVar as [Benign]. Clinvar id is 381407.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.111 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG4 | NM_015386.3 | c.2236-16A>G | intron_variant | ENST00000323786.10 | NP_056201.2 | |||
COG4 | NM_001195139.2 | c.2161-16A>G | intron_variant | NP_001182068.2 | ||||
COG4 | NM_001365426.1 | c.1810-16A>G | intron_variant | NP_001352355.1 | ||||
COG4 | NR_158212.1 | n.2195-16A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COG4 | ENST00000323786.10 | c.2236-16A>G | intron_variant | 1 | NM_015386.3 | ENSP00000315775.5 |
Frequencies
GnomAD3 genomes AF: 0.0325 AC: 4943AN: 151958Hom.: 298 Cov.: 32
GnomAD3 genomes
AF:
AC:
4943
AN:
151958
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00795 AC: 1982AN: 249418Hom.: 109 AF XY: 0.00604 AC XY: 816AN XY: 135070
GnomAD3 exomes
AF:
AC:
1982
AN:
249418
Hom.:
AF XY:
AC XY:
816
AN XY:
135070
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00317 AC: 4625AN: 1460930Hom.: 244 Cov.: 33 AF XY: 0.00276 AC XY: 2007AN XY: 726814
GnomAD4 exome
AF:
AC:
4625
AN:
1460930
Hom.:
Cov.:
33
AF XY:
AC XY:
2007
AN XY:
726814
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0325 AC: 4942AN: 152076Hom.: 297 Cov.: 32 AF XY: 0.0318 AC XY: 2362AN XY: 74370
GnomAD4 genome
AF:
AC:
4942
AN:
152076
Hom.:
Cov.:
32
AF XY:
AC XY:
2362
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 23, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
COG4-congenital disorder of glycosylation Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at